Allergy and Immunology · Jackson, TN
NPI
1598750184
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
464 N Parkway, Suite D
Jackson, TN, 38305
Phone (731) 660-0138
Groups this clinician bills Medicare through
Medicare paid, 2024
$458K
19,541 services
Medicare patients, 2024
288
Average age 72
Drug cost, 2024
$1.9M
1,240 prescriptions
Company payments, 2025
$1,995
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan C Dejarnatt was code J2357 (injection, omalizumab, 5 mg), 9,242 times for 17 patients. In total Alan C Dejarnatt billed 19,541 services in 24 codes, and Medicare paid $458K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 9,242 | 17 | $29.72 | $275K |
| 95004 Test - Miscellaneous | Office | 3,073 | 68 | $2.32 | $7,134 |
| 95165 Treatment - Miscellaneous | Office | 1,860 | 96 | $9.50 | $18K |
| 95024 Test - Miscellaneous | Office | 516 | 37 | $5.54 | $2,858 |
| 95117 Treatment - Miscellaneous | Office | 499 | 24 | $7.93 | $3,958 |
| 95115 Treatment - Miscellaneous | Office | 436 | 32 | $5.78 | $2,520 |
| 96372 Injection Administration | Office | 361 | 26 | $10.32 | $3,725 |
| 99213 Office E&M - Established | Office | 164 | 157 | $56.10 | $9,201 |
| 99203 Office E&M - New | Office | 61 | 61 | $70.09 | $4,276 |
| 99204 Office E&M - New | Office | 42 | 42 | $102.68 | $4,313 |
| 94375 Pulmonary Function Testing | Office | 40 | 40 | $25.47 | $1,019 |
| 96160 E&M - Miscellaneous | Office | 30 | 30 | $1.75 | $52.47 |
| 99214 Office E&M - Established | Office | 21 | 21 | $89.48 | $1,879 |
| 99211 Office E&M - Established | Office | 14 | 14 | $16.76 | $235 |
| 94010 Pulmonary Function Testing | Office | 12 | 12 | $14.51 | $174 |
By year: 2022 $287K for 13,728 services; 2023 $368K for 17,676 services; 2024 $458K for 19,541 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan C Dejarnatt prescribed most often to Medicare patients was Azelastine Hcl, with 227 prescriptions and refills. In total Alan C Dejarnatt wrote 1,240 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 227 | 317 | 118 | $6,027 |
| Fluticasone Propionate Generic | 226 | 375 | 93 | $2,979 |
| Ipratropium Bromide Generic | 85 | 96 | 31 | $2,064 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 76 | 82 | 32 | $2,401 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 53 | 62 | 12 | $38K |
| Icatibant Icatibant Acetate | 44 | 44 | Under 11 | $767K |
| Dupixent Pen Dupilumab | 43 | 43 | Under 11 | $171K |
| Breo Ellipta Fluticasone/Vilanterol | 33 | 39 | Under 11 | $13K |
| Montelukast Sodium Generic | 33 | 85 | 11 | $460 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 27 | 37 | Under 11 | $4,405 |
| Epinephrine Generic | 24 | 26 | 18 | $5,349 |
| Levocetirizine Dihydrochloride Generic | 23 | 40 | Under 11 | $179 |
| Doxycycline Hyclate Generic | 21 | 21 | 20 | $429 |
| Advair Hfa Fluticasone Propion/Salmeterol | 21 | 21 | Under 11 | $7,080 |
| Celecoxib Generic | 20 | 20 | Under 11 | $610 |
Brand drugs: - claims; generic drugs: 874 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan C Dejarnatt $1,995 ($1,995 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $347.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $347 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $293 |
| Genzyme Corporation SNY | 7 | $241 |
| GlaxoSmithKline, LLC. GSK | 7 | $207 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 11 | $199 |
| CSL Behring CSL.AX | 10 | $183 |
| Genentech USA, Inc. ROG.SW | 4 | $128 |
| Amgen Inc. AMGN | 4 | $82.78 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $63.66 |
| Ionis Pharmaceuticals, Inc. IONS | 3 | $60.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.